Ellis-Behnke Rutledge G, Liang Yu-Xiang, Tay David K C, Kau Phillis W F, Schneider Gerald E, Zhang Shuguang, Wu Wutian, So Kwok-Fai
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Nanomedicine. 2006 Dec;2(4):207-15. doi: 10.1016/j.nano.2006.08.001. Epub 2006 Oct 12.
Hemostasis is a major problem in surgical procedures and after major trauma. There are few effective methods to stop bleeding without causing secondary damage. We used a self-assembling peptide that establishes a nanofiber barrier to achieve complete hemostasis immediately when applied directly to a wound in the brain, spinal cord, femoral artery, liver, or skin of mammals. This novel therapy stops bleeding without the use of pressure, cauterization, vasoconstriction, coagulation, or cross-linked adhesives. The self-assembling solution is nontoxic and nonimmunogenic, and the breakdown products are amino acids, which are tissue building blocks that can be used to repair the site of injury. Here we report the first use of nanotechnology to achieve complete hemostasis in less than 15 seconds, which could fundamentally change how much blood is needed during surgery of the future.
止血是外科手术和重大创伤后的一个主要问题。几乎没有能在不造成二次损伤的情况下有效止血的方法。我们使用了一种能形成纳米纤维屏障的自组装肽,当直接应用于哺乳动物的脑、脊髓、股动脉、肝脏或皮肤伤口时,能立即实现完全止血。这种新型疗法无需使用压力、烧灼、血管收缩、凝血或交联粘合剂就能止血。这种自组装溶液无毒且无免疫原性,其分解产物是氨基酸,而氨基酸是可用于修复损伤部位的组织构建块。在此我们报告首次利用纳米技术在不到15秒内实现完全止血,这可能会从根本上改变未来手术所需的血量。